How are VEEV strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the VEEV strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 43.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$590.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a VEEV strangle?

The breakeven for the VEEV strangle priced on this page is roughly $159.10 and $190.90 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VEEV market-implied 1-standard-deviation expected move is approximately 12.44%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current VEEV implied volatility affect this strangle?

VEEV ATM IV is at 43.40% with IV rank near 31.27%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

VEEV Strangle Strategy

VEEV (Veeva Systems Inc.), in the Healthcare sector, (Medical - Healthcare Information Services industry), listed on NYSE.

Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications.

VEEV (Veeva Systems Inc.) trades in the Healthcare sector, specifically Medical - Healthcare Information Services, with a market capitalization of approximately $27.84B, a trailing P/E of 29.73, a beta of 0.95 versus the broader market, a 52-week range of 148.05-310.5, average daily share volume of 3.1M, a public-listing history dating back to 2013, approximately 7K full-time employees. These structural characteristics shape how VEEV stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.95 places VEEV roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a strangle on VEEV?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current VEEV snapshot

As of June 29, 2026, spot at $174.82, ATM IV 43.40%, IV rank 31.27%, expected move 12.44%. The strangle on VEEV below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.

Why this strangle structure on VEEV specifically: VEEV IV at 43.40% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 12.44% (roughly $21.75 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VEEV expiries trade a higher absolute premium for lower per-day decay. Position sizing on VEEV should anchor to the underlying notional of $174.82 per share and to the trader's directional view on VEEV stock.

VEEV strangle setup

The VEEV strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VEEV near $174.82, the first option leg uses a $185.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VEEV chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VEEV shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$185.00	$3.10
Buy 1	Put	$165.00	$2.80

VEEV strangle risk and reward

Net Premium / Debit: -$590.00
Max Profit (per contract): Unbounded
Max Loss (per contract): -$590.00
Breakeven(s): $159.10, $190.90
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

VEEV strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on VEEV. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

P&L at expiration across the modeled underlying-price range. Green shading marks profitable regions, red shading marks loss regions. Dotted purple verticals mark breakevens; the solid dark vertical marks current spot.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$15,909.00
$38.66	-77.9%	+$12,043.74
$77.32	-55.8%	+$8,178.49
$115.97	-33.7%	+$4,313.23
$154.62	-11.6%	+$447.97
$193.27	+10.6%	+$237.28
$231.93	+32.7%	+$4,102.54
$270.58	+54.8%	+$7,967.79
$309.23	+76.9%	+$11,833.05
$347.88	+99.0%	+$15,698.31

When traders use strangle on VEEV

Strangles on VEEV are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the VEEV chain.

VEEV thesis for this strangle

The market-implied 1-standard-deviation range for VEEV extends from approximately $153.07 on the downside to $196.57 on the upside. A VEEV long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current VEEV IV rank near 31.27% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on VEEV should anchor more to the directional view and the expected-move geometry. As a Healthcare name, VEEV options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VEEV-specific events.

VEEV strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VEEV positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VEEV alongside the broader basket even when VEEV-specific fundamentals are unchanged. Always rebuild the position from current VEEV chain quotes before placing a trade.

Frequently asked questions

What is a strangle on VEEV?: A strangle on VEEV is the strangle strategy applied to VEEV (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With VEEV stock trading near $174.82, the strikes shown on this page are snapped to the nearest listed VEEV chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are VEEV strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the VEEV strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 43.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$590.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a VEEV strangle?: The breakeven for the VEEV strangle priced on this page is roughly $159.10 and $190.90 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VEEV market-implied 1-standard-deviation expected move is approximately 12.44%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on VEEV?: Strangles on VEEV are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the VEEV chain.
How does current VEEV implied volatility affect this strangle?: VEEV ATM IV is at 43.40% with IV rank near 31.27%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.